α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(β-phenylbenzenepropanoate) (9CI),254449-96-2-Amadis Chemical

Home > Product Catalog > Life science > Nucleosides > α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(β-phenylbenzenepropanoate) (9CI)

[CAS No.254449-96-2] A1255216 α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(β-phenylbenzenepropanoate) (9CI) 97%

Search after editing

Catalog No.: A1255216

Cas No.: 254449-96-2

Molecular Formula: C₃₉H₄₅N₅O₁₃

Molecular Weight: 791.80

MDL NO:

EINECS:

Order & Inquiry & Tech Support

Tel: 0086-571-89925085
Order & Inquiry: sales@amadischem.com
Tech Support: tech@amadischem.com

Request Quote

*All chemicals from Amadis Chemical are for laboratory or manufacturing use only.

Quality Control of [254449-96-2]

NMR

CNMR

HPLC

LC-MS

Related Doc. of[254449-96-2]

SDS

Specification

MOL

SDF

Product Details [254449-96-2]

Synonyms: α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(β-phenylbenzenepropanoate) (9CI)

Appearance:

Storage: Store in 2-8°C for long term (months)

Boiling point:

Melting point:

Flash point:

Pubchem ID:

Smiles: O(C(CC(C1=CC=CC=C1)C2=CC=CC=C2)=O)[C@H]3[C@@H](O[C@]([C@@H](O[C@H]4OC(C(N[C@H]5CCC[C@@H](C)NC5=O)=O)=C[C@H](O)[C@@H]4O)C(N)=O)([C@H]3OC)[H])N6C(=O)NC(=O)C=C6

InchiKey: PNGUZRATONWXEX-CSTPOKQTSA-N

Inchi: InChI=1S/C39H45N5O13/c1-20-10-9-15-24(35(50)41-20)42-36(51)26-19-25(45)29(48)38(54-26)57-32(34(40)49)31-30(53-2)33(37(56-31)44-17-16-27(46)43-39(44)52)55-28(47)18-23(21-11-5-3-6-12-21)22-13-7-4-8-14-22/h3-8,11-14,16-17,19-20,23-25,29-33,37-38,45,48H,9-10,15,18H2,1-2H3,(H2,40,49)(H,41,50)(H,42,51)(H,43,46,52)/t20-,24+,25+,29+,30-,31+,32-,33-,37-,38-/m1/s1

Safety [254449-96-2]

GHS Pictogram:

Signal Word: Warning

Class:

Precautionary Statements: P261;P280;P305+P351+P338

UN No.:

Hazard Statements: H302;H315;H319;H332;H335

Packing Group:

Literatures [254449-96-2]

Sorry, the literature is not available.

Similar of [254449-96-2]

A1255091 1194506-21-2

α-L-Talofuranuronamide, 5-O-[3-O-(11-amino-1-oxoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)

Reason:Nucleosides

A1255098 1283084-06-9

α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(11-aminoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)

Reason:Nucleosides

A1255102 254449-78-0

α-L-Talofuranuronamide, 5-O-[3-O-[(decyloxy)carbonyl]-4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:Nucleosides

A1255103 254449-62-2

α-L-Talofuranuronamide, 5-O-[3-O-[(decyloxy)carbonyl]-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:Nucleosides

A1255132 1442691-96-4

α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(11-amino-1-oxoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(11-aminoundecanoate) (ACI)

Reason:Nucleosides

A1255135 1283084-07-0

α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(10-aminodecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)

Reason:Nucleosides

A1255137 1194506-23-4

α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(15-amino-1-oxo-4,7,10,13-tetraoxapentadec-1-yl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)

Reason:Nucleosides

A1255138 1194506-22-3

α-L-Talofuranuronamide, 5-O-[3-O-(15-amino-1-oxo-4,7,10,13-tetraoxapentadec-1-yl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)

Reason:Nucleosides

A1255151 360772-38-9

α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI)

Reason:Nucleosides

A1255211 254450-44-7

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-nonanoate (9CI)

Reason:Nucleosides

Description [254449-96-2]

Sorry, the product description is not available.